Feature in Biopharma Dealmakers issues
Engage partners from the biopharma and investment community.
Explore upcoming opportunities with Biopharma Dealmakers to connect with top industry scientists, biotech and pharma C-level executives, business development in big pharma, as well as the VC and investor community.
Book your spot:
- View our upcoming issues to find the perfect fit for your organization!
- Chat to us about your preferred communication channels – we offer:
- Branded content. Examples: Eli Lilly (Point Biopharma) and Janssen Oncology.
- Digital and print advertising
- Webcasts
- Email marketing and e-alert advertising. Journal e-alerts include: Nature Biotechnology, Nature Reviews Drug Discovery, and Biopharma Dealmakers.
Audiences we can help you reach: 6 examples
Biotechnology
94 Journals & 44.6 Million monthly page views
Cancer Biology
59 Journals & 47.4 Million monthly page views
Drug Development
109 Journals & 36.8 Million monthly page views
Infectious Diseases
37 Journals & 15.7 Million monthly page views
Immunology
40 Journals & 20.1 Million monthly page views
Oncology
119 Journals & 17 Million monthly page views
2026 Biopharma Dealmakers Issues Calendar:
View the themes below and get in touch before the booking deadlines.
| Publication month | Type of issue | Themes | Conference distribution | Booking deadline |
|---|---|---|---|---|
| February 2026 | Online collection | Autoimmune disorders, including inflammation, and immunological disorders | BIO-Europe Spring (Lisbon, March 31 – April 1) American Association for Cancer Research (AACR) annual meeting (San Diego, USA, April 17-22) Bio-Trinity (London, UK, April 14-15) | 14th November 2025 |
| March 2026 | Full print issue | Therapy –Endocrinology/cardiovascular/metabolic diseases including GLP-1 drugs, diabetes, obesity, and weight loss Tech/industry – Precision medicine, including diagnostics, next-generation sequencing | BIO-Europe Spring (Lisbon, March 31 – April 1) American Association for Cancer Research (AACR) annual meeting (San Diego, USA, April 17-22) Bio-Trinity (London, UK, April 14 – 15) | 3rd December 2025 |
| April 2026 | Online collection | RNA technologies and nucleic acid-based drugs | Bio International Convention (San Diego, June 22-25) | 21st January 2026 |
| May 2026 | Online collection | Biomanufacturing/supply, including sustainable/greener practices | Bio International Convention (San Diego, June 22-25) | 18th February 2026 |
| June 2026 | Full print issue | Therapy – Oncology Tech – Artificial intelligence (AI)/machine learning (ML) technologies, including big data, cloud and quantum computing | Bio International Convention (San Diego, June 22 -25) | 9th March 2026 |
| July 2026 | Online collection | Ophthalmology | BioPharm America (Boston, USA, September) Bio-Europe (November) Society for Neuroscience annual meeting (Washington DC, Nov 15-17) | 20th April 2026 |
| September 2026 | Full print issue | Therapy – Neurodegeneration including aging Tech/industry – Antibodies/ADCs Infectious diseases including vaccines/take-up | BioPharm America (Boston, USA, September) Bio-Europe (November) Society for Neuroscience annual meeting (Washington DC, Nov 15 -17) | 5th June 2025 |
| October 2026 | Online collection | Protein technologies including protein degradation | JP Morgan/Biotech Showcase (San Francisco, USA, 2027) | 22nd July 2026 |
| November 2026 | Online collection | Rare diseases and orphan drugs | JP Morgan/Biotech Showcase (San Francisco, USA, 2027) | 21st August 2026 |
| December 2026 | Full print issue | Oncology, including a spotlight on radiopharmaceuticals Tech – Cell/gene therapy, regenerative technologies | JP Morgan/Biotech Showcase (San Francisco, USA, 2027) | 7th September 2026 |
2025 Biopharma Dealmakers Issues Calendar:
View the themes below and get in touch before the booking deadlines.
| Publication month | Type of issue | Themes | Conference distribution | Spotlight region | Booking deadline |
|---|---|---|---|---|---|
| February | Online collection | Metabolic diseases – including obesity and diabetes | BIO-Europe Spring (Milan, 17 – 19 March) American Association for Cancer Research (AACR) annual meeting (Chicago, USA, 25 – 30 April) Bio-Trinity (London, UK, 1 – 2 April) | 12 Nov 2024 | |
| March | Full issue | Oncology – solid tumours Drug delivery | BIO-Europe Spring (Milan, 17-19 March) American Association for Cancer Research (AACR) annual meeting (Chicago, USA, 25 – 30 April) Bio-Trinity (London, UK, 1 – 2 April) | Canada | 3 Dec 2024 |
| May | Online collection | Precision medicine – including genetic sequencing, gene editing and molecular diagnostics | Bio International Convention (Boston, 16 – 19 June) | 12 Feb 2025 | |
| June | Full issue | Infectious diseases – including AMR AI/ML/Big data, generative AI | Bio International Convention (Boston, 16 – 19 June) | East coast USA including Boston, New York and Philadelphia | 3 Mar 2025 |
| July | Online collection | RNA technologies Nucleic-acid based drugs | BioPharm America (Boston, USA, 11 – 12 September) Bio-Europe (Vien na, 3 – 5 November) Society for Neuroscience annual meeting (San Diego, USA, 15 -19 October) | 9 Apr 2025 | |
| September | Full issue | Neurodegenerative disorders – including Alzheimer’s disease and dementia and/or Aging/longevity Antibody technologies, including ADCs | BioPharm America (Boston, USA, 11 -12 September) Bio-Europe (Vienna, 3 – 5 November) Society for Neuroscience annual meeting (San Diego, USA, 15 -19 October) | Europe | 3 Jun 2025 |
| October | Online collection | Protein technologies – including protein degradation | JP Morgan/Biotech Showcase (San Francisco, USA, 2026) | 15 Jul 2025 | |
| November | Online collection | Haematological disorders – including blood clotting and haemophilia | JP Morgan/Biotech Showcase (San Francisco, USA, 2026) | 15 Aug 2025 | |
| December | Full issue | Oncology – approaches used in treatments, including nanomedicines and radiopharmaceuticals Regenerative medicine (including CRISPR, cell & gene therapies, gene editing) | JP Morgan/Biotech Showcase (San Francisco, USA, 2026) | USA (San Francisco & Texas) | 1 Sep 2025 |
Advertise in Biopharma Dealmakers issues
"*" indicates required fields
